2,223
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis

ORCID Icon, , , , , , , ORCID Icon & ORCID Icon show all
Pages 301-309 | Received 25 May 2022, Accepted 14 Sep 2022, Published online: 10 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yiyue Xu, Haoqian Li, Xiaoqing Wang, Butuo Li, Aiqin Gao, Qian Zhao, Linlin Yang, Wenru Qin & Linlin Wang. (2024) Development and Validation of Nomograms for Predicting Pneumonia in Patients with COVID-19 and Lung Cancer. Journal of Inflammation Research 17, pages 3671-3683.
Read now

Articles from other publishers (2)

Qinan Yin, Liuyun Wu, Lizhu Han, Xingyue Zheng, Rongsheng Tong, Lian Li, Lan Bai & Yuan Bian. (2023) Immune-related adverse events of immune checkpoint inhibitors: a review. Frontiers in Immunology 14.
Crossref
Adilai Aisa, Shanshan Weng, Xinyu Li, Ding Zhang & Ying Yuan. (2022) Immune checkpoint inhibitors combined with HER-2 targeted therapy in HER-2 positive gastroesophageal cancer. Critical Reviews in Oncology/Hematology 180, pages 103864.
Crossref